Michael Benkowitz sold $3.7M of UTHR
PRESIDENT AND COO at UNITED THERAPEUTICS Corp. 10,000 shares at an average of $370.51, traded Dec 2, 2024, filed Dec 3, 2024.
Score components
- +20RolePresident
- +25Trade size$3.7M at market
- +20Share of holdings soldSold 100% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001415889-24-028092, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 2, 2024 | MOption exercise Common Stockindirect: By Trust10b5-1 | +7,500 | $102.11 | $766k | 7,500 | Dec 3, 2024 |
| Dec 2, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -200 | $368.01 | $74k | 7,300 | Dec 3, 2024 |
| Dec 2, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -1,779 | $369.50 | $657k | 5,521 | Dec 3, 2024 |
| Dec 2, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -3,859 | $370.38 | $1.4M | 1,662 | Dec 3, 2024 |
| Dec 2, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -1,162 | $371.42 | $432k | 400 | Dec 3, 2024 |
| Dec 2, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -400 | $372.37 | $149k | 100 | Dec 3, 2024 |
| Dec 2, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -100 | $374.46 | $37k | 0 | Dec 3, 2024 |
| Dec 2, 2024 | MOption exercise Common Stockindirect: By Trust10b5-1 | +2,500 | $111.00 | $278k | 2,500 | Dec 3, 2024 |
| Dec 2, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -506 | $369.52 | $187k | 1,994 | Dec 3, 2024 |
| Dec 2, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -1,194 | $370.43 | $442k | 800 | Dec 3, 2024 |
| Dec 2, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -600 | $371.50 | $223k | 200 | Dec 3, 2024 |
| Dec 2, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -100 | $372.37 | $37k | 100 | Dec 3, 2024 |
| Dec 2, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -100 | $374.48 | $37k | 0 | Dec 3, 2024 |
| Dec 2, 2024 | MOption exercise Stock Optionsderivativeindirect: By Trust10b5-1 | -7,500 | $0.00 | $0 | 4,500 | Dec 3, 2024 |
| Dec 2, 2024 | MOption exercise Stock Optionsderivativeindirect: By Trust10b5-1 | -2,500 | $0.00 | $0 | 34,500 | Dec 3, 2024 |
Related signals
Other insiders at UNITED THERAPEUTICS Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $5.1M 9,500 shares | -3% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $5.2M 9,500 shares | -3% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $5.1M 9,500 shares | -3% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $5.1M 9,500 shares | -3% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $5.2M 9,500 shares | -3% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $5.5M 9,500 shares | -3% | |
| 18Weak | UNITED THERAPEUTICS Corp | Paul A Mahon EVP & GENERAL COUNSEL | $4.7M 8,300 shares | -16% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $3.9M 7,580 shares | -2% | |
| 38Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $1.1M 1,920 shares | -1% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $4.5M 9,500 shares | -3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.